ReviewFrontiers in immunology2018

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.

Kerry S Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.